A Phase II Study of Optimized Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma.

Daniel J Herr Chang Wang Mishal Mendiratta-Lala Martha Matuszak Charles S Mayo Yue Cao Neehar D Parikh Randy Ten Haken Dawn Owen Joseph R Evans Teodor Stanescu Michael Yan Laura A Dawson Matthew J Schipper Theodore S Lawrence Kyle C Cuneo

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)

Treatment of individuals with impaired liver function or tumors not amenable to thermal ablation with a treatment paradigm designed to optimize utility may decrease treatment-related toxicity while maintaining tumor control.

Keyphrases

radiation therapy
phase ii study
randomized controlled trial
squamous cell carcinoma
clinical trial
open label
locally advanced
radiation induced
drug induced